Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy

Heart ◽  
2016 ◽  
Vol 102 (8) ◽  
pp. 602-609 ◽  
Author(s):  
Damiano Magrì ◽  
Giuseppe Limongelli ◽  
Federica Re ◽  
Piergiuseppe Agostoni ◽  
Elisabetta Zachara ◽  
...  
Circulation ◽  
2020 ◽  
Vol 142 (3) ◽  
pp. 217-229 ◽  
Author(s):  
Anastasia Miron ◽  
Myriam Lafreniere-Roula ◽  
Chun-Po Steve Fan ◽  
Katey R. Armstrong ◽  
Andreea Dragulescu ◽  
...  

2015 ◽  
Vol 68 (6) ◽  
pp. 544
Author(s):  
Marina Martínez-Moreno ◽  
Vicente Climent ◽  
Antonio García-Honrubia ◽  
Francisco Marín

EP Europace ◽  
2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii128-iii128
Author(s):  
C-K Antoniou ◽  
K. Gatzoulis ◽  
S. Georgopoulos ◽  
A. Anastasakis ◽  
A. Theopistou ◽  
...  

Diagnostics ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1519
Author(s):  
Ivana P. Nedeljkovic ◽  
Vojislav Giga ◽  
Marina Ostojic ◽  
Ana Djordjevic-Dikic ◽  
Tamara Stojmenovic ◽  
...  

COVID-19 infection in athletes usually has a milder course, but in the case of complications, myocarditis and even sudden cardiac death may occur. We examined an athlete who felt symptoms upon returning to training after asymptomatic COVID-19 infection. Physical, laboratory, and echocardiography findings were normal. The cardiopulmonary exercise test was interrupted at submaximal effort due to severe dyspnea in the presence of reduced functional capacity in comparison to previous tests. Cardiac magnetic resonance (CMR) detected the focal myocarditis. After three months of recovery, CMR still revealed the presence of focal myocarditis and the persistence of decreased functional capacity. This case raises the question of screening athletes even after asymptomatic forms of COVID-19 infection.


Sign in / Sign up

Export Citation Format

Share Document